Literature DB >> 1872173

Linear growth in children with cystic fibrosis. I. Birth to 8 years of age.

J Karlberg1, I Kjellmer, B Kristiansson.   

Abstract

The linear growth of Swedish children with cystic fibrosis (CF), is described using the infancy-childhood-puberty (ICP) growth model. Length/height was studied in 51 patients during their first 8 years of life. The median age at diagnosis was 0.4 years (range 0.0-6.1 years). At birth, their mean length was close to normal, but the gain in length over the first 0.25 years of life was significantly below normal, resulting in a mean length SDS of -1.3. Length remained subnormal up to 1.0 year of age. Thereafter, catch-up growth occurred, resulting in almost normal height (mean SDS-0.3) at 5.0 years of age. Between 5.0 and 8.0 years of age growth was normal. The mean age at onset of the childhood component was not significantly different from the controls. Hence, the catch-up growth did not occur until after the onset of the childhood component. This study shows that the postnatal linear growth rate is retarded in children with CF during the first months of life. This is almost completely compensated for by a supranormal growth rate that starts at the end of the first year of life.

Entities:  

Mesh:

Year:  1991        PMID: 1872173     DOI: 10.1111/j.1651-2227.1991.tb11894.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  11 in total

Review 1.  Growth and growth charts in cystic fibrosis.

Authors:  Leena Patel; Moira Dixon; T J David
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

3.  Head growth in cystic fibrosis following early diagnosis by neonatal screening.

Authors:  S Ghosal; C J Taylor; M Pickering; J McGaw
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

4.  Disproportionate head growth retardation in cystic fibrosis.

Authors:  S Ghosal; C J Taylor; M Pickering; J McGaw; N Beckles-Willson; J K Wales
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

5.  Perspectives of longitudinal growth in cystic fibrosis from birth to adult age.

Authors:  G Haeusler; H Frisch; T Waldhör; M Götz
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

Review 6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 7.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

8.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

Review 9.  Trends in Growth and Maturation in Children with Cystic Fibrosis Throughout Nine Decades.

Authors:  Kelly A Mason; Alan D Rogol
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

10.  To determine frequency of etiological factors in short statured patients presenting at an endocrine clinic of a tertiary care hospital.

Authors:  Shazia Kulsom Lashari; Hussain Bux Korejo; Yasmeen Memon Memon
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.